{"id":1916,"date":"2019-09-26T19:49:29","date_gmt":"2019-09-26T17:49:29","guid":{"rendered":"https:\/\/idibell.cat\/?page_id=1916"},"modified":"2024-12-19T13:22:52","modified_gmt":"2024-12-19T12:22:52","slug":"neuro-oncology-unit","status":"publish","type":"page","link":"https:\/\/idibell.cat\/en\/research\/cancer-area\/molecular-mechanisms-and-experimental-therapy-in-oncology-program-oncobell\/neuro-oncology-unit\/","title":{"rendered":"Neuro-Oncology Unit"},"content":{"rendered":"\n

\n\t\tNeuro-oncology unit\n\t<\/h1>\n

\n\t\tSummary\n\t<\/h3>\n\t

The Neuro-oncology group is focused in the study of brain tumor treatments and the neurological complications related with cancer and cancer treatments. The group’s aim is to create and reinforce a research network between clinical and preclinical researchers, both within and outside the institution, to provide novel therapeutic options for the patients, improve the diagnostic tools and contribute to increase the knowledge in these fields.<\/p>\n

379<\/h2>\n

Publications<\/h2>\n\t\t\t\t\"119-neurooncologia-jbruna-def\"\n\t\t\t\t\tStrategic lines<\/a>\n\t\t\t\t\t\t\t\t\t\t\tExpand<\/i><\/a>\n\t\t\t\t\tAssessment of new drugs and new treatment approaches for gliomas and meningiomas (Jordi Bruna, Carles Mesia, Ana Lucas, Carles Maj\u00f3s, Gerard Plans)
\nChemotherapy-induced peripheral neuropathies (Jordi Bruna, Roser Velasco)
\nCancer and cognition (Marta Sim\u00f3)
\nLeptomeningeal metastases (Jordi Bruna)
\nSurvival prognostic factors involved in central nervous system tumours (Noem\u00ed Vidal, Jordi Bruna, Carles Maj\u00f3s. Albert Pons)
\nPrevention and personalised treatment of brain metastases: development of new therapies based on the prevention and prognosis of biomarkers (Carles Mesia, Noem\u00ed Vidal, Gerard Plans, Ana Lucas)
\nQuantitative assessment of advanced MR techniques in clinical neurooncology (Carles Majos, Albert Pons)\n\t\t\t\t\t
Selected Publications<\/a>\n\t\t\t\t\t\t\t\t\t\t\tExpand<\/i><\/a>\n\t\t\t\t\t